BioLife Sciences Inc. (BLFE)
USD 0.0
(9900.0%)
USD 0.0
(9900.0%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2022 | - USD | 0.0% |
| 2021 | - USD | 100.0% |
| 2020 | -1.24 Million USD | 0.0% |
| 2019 | - USD | 100.0% |
| 2018 | -42.28 Thousand USD | 87.15% |
| 2017 | -329.13 Thousand USD | -2533.04% |
| 2016 | -12.5 Thousand USD | 40.93% |
| 2015 | -21.16 Thousand USD | 0.0% |
| 2007 | 39.32 Thousand USD | -68.67% |
| 2006 | 125.5 Thousand USD | 123.82% |
| 2005 | -526.81 Thousand USD | -2469.82% |
| 2004 | -20.5 Thousand USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 Q2 | - USD | 0.0% |
| 2023 Q1 | - USD | 0.0% |
| 2023 Q3 | - USD | 0.0% |
| 2022 Q1 | -122.80 USD | 0.0% |
| 2022 Q4 | - USD | 0.0% |
| 2022 FY | - USD | 0.0% |
| 2022 Q3 | - USD | 0.0% |
| 2021 FY | - USD | 100.0% |
| 2021 Q2 | -126.23 Thousand USD | -120.3% |
| 2021 Q1 | -57.3 Thousand USD | 0.0% |
| 2021 Q3 | -134.76 Thousand USD | -6.76% |
| 2020 FY | -1.24 Million USD | 0.0% |
| 2019 FY | - USD | 100.0% |
| 2018 FY | -42.28 Thousand USD | 87.15% |
| 2017 FY | -329.13 Thousand USD | -2533.04% |
| 2016 FY | -12.5 Thousand USD | 40.93% |
| 2015 FY | -21.16 Thousand USD | 0.0% |
| 2008 Q2 | 84.15 Thousand USD | 175.34% |
| 2008 Q1 | -111.69 Thousand USD | -12.5% |
| 2007 Q2 | 159.94 Thousand USD | 88.04% |
| 2007 Q4 | -99.28 Thousand USD | -1096.6% |
| 2007 Q1 | 85.05 Thousand USD | 999.21% |
| 2007 FY | 39.32 Thousand USD | -68.67% |
| 2007 Q3 | 9962.00 USD | -93.77% |
| 2006 Q2 | 1.12 Million USD | 851.1% |
| 2006 FY | 125.5 Thousand USD | 123.82% |
| 2006 Q4 | -9459.00 USD | -103.38% |
| 2006 Q1 | -149.37 Thousand USD | 63.72% |
| 2006 Q3 | 280.01 Thousand USD | -75.04% |
| 2005 Q1 | -3500.00 USD | 0.0% |
| 2005 Q2 | 35.5 Thousand USD | 1114.29% |
| 2005 Q3 | -76.12 Thousand USD | -314.43% |
| 2005 FY | -526.81 Thousand USD | -2469.82% |
| 2005 Q4 | -411.69 Thousand USD | -440.84% |
| 2004 FY | -20.5 Thousand USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| American Medical Technologies Inc. | 1.16 Million USD | 100.0% |
| Ansell Limited | 129.3 Million USD | 100.0% |
| Ansell Limited | 129.3 Million USD | 100.0% |
| BG Medicine, Inc. | - USD | NaN% |
| Biotage AB (publ) | 31.13 Million USD | 100.0% |
| CB Scientific, Inc. | -1.59 Million USD | 100.0% |
| Psykey, Inc. | -797.5 Thousand USD | 100.0% |
| ConvaTec Group Plc | 262.7 Million USD | 100.0% |
| ConvaTec Group Plc | 262.7 Million USD | 100.0% |
| Encision Inc. | -640.78 Thousand USD | 100.0% |
| Golden Valley Development, Inc | -141.81 Thousand USD | 100.0% |
| Hear AtLast Holdings, Inc. | -109.93 Thousand USD | 100.0% |
| Innovative MedTech Inc. | -4.27 Million USD | 100.0% |
| LifePoint, Inc. | -7.49 Million USD | 100.0% |
| Medite Cancer Diagnostics, Inc. | -6.48 Million USD | 100.0% |
| Paradigm Medical Industries, Inc. | 330 Thousand USD | 100.0% |
| QuantRx Biomedical Corporation | - USD | NaN% |
| Remedent, Inc. | -122.89 Thousand USD | 100.0% |
| Reflect Scientific, Inc. | -467.27 Thousand USD | 100.0% |
| SmileDirectClub, Inc. | -241.15 Million USD | 100.0% |
| Sector 10, Inc. | -39.84 Thousand USD | 100.0% |
| Shandong Weigao Group Medical Polymer Company Limited | 319.6 Million USD | 100.0% |
| SheerVision, Inc. | 155.72 Thousand USD | 100.0% |
| United Health Products, Inc. | -2.42 Million USD | 100.0% |
| Vasamed, Inc. | 4.74 Million USD | 100.0% |
| Wearable Health Solutions, Inc. | -2.29 Million USD | 100.0% |
| Yubo International Biotech Limited | -1.2 Million USD | 100.0% |